First Eagle Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-50,000
| Closed | -$100K | – | 295 |
|
|
2017
Q4 | $100K | Hold |
50,000
| – | – | ﹤0.01% | 272 |
|
|
2017
Q3 | $162K | Buy |
50,000
+30,000
| +150% | +$97.2K | ﹤0.01% | 280 |
|
|
2017
Q2 | $64K | Hold |
20,000
| – | – | ﹤0.01% | 277 |
|
|
2017
Q1 | $57K | Hold |
20,000
| – | – | ﹤0.01% | 276 |
|
|
2016
Q4 | $47K | Hold |
20,000
| – | – | ﹤0.01% | 281 |
|
|
2016
Q3 | $34K | Hold |
20,000
| – | – | ﹤0.01% | 301 |
|
|
2016
Q2 | $21K | Hold |
20,000
| – | – | ﹤0.01% | 323 |
|
|
2016
Q1 | $17K | Hold |
20,000
| – | – | ﹤0.01% | 309 |
|
|
2015
Q4 | $24K | Hold |
20,000
| – | – | ﹤0.01% | 295 |
|
|
2015
Q3 | $34K | Hold |
20,000
| – | – | ﹤0.01% | 280 |
|
|
2015
Q2 | $42K | Hold |
20,000
| – | – | ﹤0.01% | 274 |
|
|
2015
Q1 | $54K | Hold |
20,000
| – | – | ﹤0.01% | 286 |
|
|
2014
Q4 | $51K | Hold |
20,000
| – | – | ﹤0.01% | 292 |
|
|
2014
Q3 | $37K | Hold |
20,000
| – | – | ﹤0.01% | 296 |
|
|
2014
Q2 | $53K | Hold |
20,000
| – | – | ﹤0.01% | 283 |
|
|
2014
Q1 | $70K | Hold |
20,000
| – | – | ﹤0.01% | 338 |
|
|
2013
Q4 | $90K | Hold |
20,000
| – | – | ﹤0.01% | 317 |
|
|
2013
Q3 | $81K | Hold |
20,000
| – | – | ﹤0.01% | 304 |
|
|
2013
Q2 | $83K | Buy |
+20,000
| New | +$83K | ﹤0.01% | 306 |
|